Causal relationship and mediating role between depression and cognitive performance Xinyu Hao, Fuyang Cao, Ziyao Xu, Shaohua You, Tianyue Mi, Lei Wang, Yongxin Guo, Zhuoning Zhang, Jiangbei Cao, Jingsheng Lou, Yanhong Liu, Xianyang Chen, Zhikang Zhou, Weidong Mi, Li Tong The Journal of Prevention of Alzheimer's Disease.2025; 12(8): 100196. CrossRef
Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidance Lanlan Chen, Qi Rao, Menghan Gao, Guoyue Lv, Frank Tacke Clinical and Molecular Hepatology.2025; 31(4): 1115. CrossRef
Serum complement C3 as a diagnostic biomarker for metabolic dysfunction -associated steatotic liver disease in middle-aged and elderly adults: a cross-sectional study Dan Ye, Haifen Ma, Jingjing Zhou, Jiaofeng Wang, Jiaheng Shi, Jie Chen, Zhijun Bao, Xiaona Hu BMC Gastroenterology.2025;[Epub] CrossRef
Reassessing the Impact of Coffee Consumption on Liver Disease: Insights from a Large-Scale Cohort Study with IPTW Adjustment Keungmo Yang, Young Chang, Soung Won Jeong, Jae Young Jang, Tom Ryu Nutrients.2024; 16(13): 2020. CrossRef
Impact of Physical Activity on Overall Survival and Liver Cirrhosis Incidence in Steatotic Liver Disease: Insights from a Large Cohort Study Using Inverse Probability of Treatment Weighting Keungmo Yang, Beom Sun Chung, Tom Ryu Nutrients.2024; 16(15): 2532. CrossRef
Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets” Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang Clinical and Molecular Hepatology.2024; 30(4): 1037. CrossRef
Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets” Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu Clinical and Molecular Hepatology.2024; 30(4): 987. CrossRef
First
Prev
